MEDIROM Healthcare Technologies Inc.
MRM · NASDAQ
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $1 | $3 | $4 | $4 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $4 | $4 | $4 | $3 |
| Enterprise Value | $4 | $7 | $8 | $7 |
| Revenue | $5 | $3 | $4 | $3 |
| % Growth | 38.8% | -3.1% | 10.6% | – |
| Gross Profit | $2 | $1 | $1 | $1 |
| % Margin | 34.6% | 16.6% | 24.8% | 20.9% |
| EBITDA | $1 | -$0 | $0 | -$0 |
| % Margin | 17.2% | -12.7% | 2% | -6.5% |
| Net Income | $1 | -$1 | $0 | -$0 |
| % Margin | 15.2% | -16.8% | 13.1% | -10.9% |
| EPS Diluted | 118.73 | -118.56 | 86.32 | -72.72 |
| % Growth | 200.1% | -237.3% | 218.7% | – |
| Operating Cash Flow | -$1 | -$1 | -$0 | -$1 |
| Capital Expenditures | -$1 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$1 | -$1 | -$0 | -$1 |